Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACC 2021
Biotech
Cytokinetics preps omecamtiv for support role in heart failure
Cytokinetics will showcase the narrower population of patients who may benefit from omecamtiv mecarbil at the American College of Cardiology meeting.
Annalee Armstrong
May 17, 2021 8:00am
ACC: Study finds no increased death risk with paclitaxel devices
May 16, 2021 5:30pm
ACC: Heart ultrasound AI accurately predicts COVID-19 death risk
May 16, 2021 12:26pm
ACC: ReCor's renal denervation device cuts drug-resistant BP
May 16, 2021 10:45am
BMS unveils more mavacamten data, nabbed in $13B MyoKardia deal
May 15, 2021 12:15pm
ACC: Edwards' tricuspid valve cuts leaks in 98% of patients
May 15, 2021 12:15pm
